ARCHIVES

NCAB Approves OIA Awards For At Least 21 Scientist, More If Payline Lifted

This article is from The Cancer Letter archive.

Vol. 11 No. 21 | May 24, 1985

Download PDF Visit The Full Archive

Related Articles

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

NCI to set separate payline for R01s over $700,000.

February 13, 2004

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991

Clinical Trials Approved By NCI CTEP During July

August 30, 2002

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998